{"entity":{"type":"insider","cik":"0001382629","url":"/insider/0001382629","json_url":"/insider/0001382629.json","name":"Belsky Marc","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":8,"first":"2016-03-31","last":"2020-02-05","span_basis":"filed_date"},"name_variants":[{"name":"Belsky Marc","source":"filing","n_filings":8,"first_seen":"2016-03-31","last_seen":"2020-02-05"}],"transactions":[{"id":2066126,"accession":"0001209191-20-007057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-007057","line_url":"/filing/0001209191-20-007057#line-1","is_derivative":false,"issuer_cik":"0001382629","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001382629","owner_cik":"0001382629","owner_name":"Belsky Marc","owner_display_name":"Belsky Marc","owner_url":"/insider/0001382629","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15384.0,"shares_display":"15,384","price_per_share":2.6,"price_display":"2.60","price_state":"stated","total_value":39998.4,"total_display":"39,998.40","total_whole":"39,998","shares_owned_after":15384.0,"shares_owned_after_display":"15,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-04","filed_date":"2020-02-05","scope":"insider"},{"id":8102870,"accession":"0001209191-19-056481","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-056481","line_url":"/filing/0001209191-19-056481#line-1","is_derivative":false,"issuer_cik":"0001382629","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001382629","owner_cik":"0001382629","owner_name":"Belsky Marc","owner_display_name":"Belsky Marc","owner_url":"/insider/0001382629","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":2.7588,"price_display":"2.76","price_state":"stated","total_value":2207.04,"total_display":"2,207.04","total_whole":"2,207","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-13","filed_date":"2019-11-13","scope":"insider"},{"id":7950897,"accession":"0001209191-19-047057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-047057","line_url":"/filing/0001209191-19-047057#line-1","is_derivative":false,"issuer_cik":"0001382629","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001382629","owner_cik":"0001382629","owner_name":"Belsky Marc","owner_display_name":"Belsky Marc","owner_url":"/insider/0001382629","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":4.42,"price_display":"4.42","price_state":"stated","total_value":884.0,"total_display":"884.00","total_whole":"884","shares_owned_after":1200.0,"shares_owned_after_display":"1,200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-21","scope":"insider"},{"id":8515765,"accession":"0001209191-19-045642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-045642","line_url":"/filing/0001209191-19-045642#line-1","is_derivative":false,"issuer_cik":"0001382629","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001382629","owner_cik":"0001382629","owner_name":"Belsky Marc","owner_display_name":"Belsky Marc","owner_url":"/insider/0001382629","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":4.82,"price_display":"4.82","price_state":"stated","total_value":2410.0,"total_display":"2,410.00","total_whole":"2,410","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-09","filed_date":"2019-08-12","scope":"insider"},{"id":7871937,"accession":"0001209191-19-043385","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-043385","line_url":"/filing/0001209191-19-043385#line-2","is_derivative":false,"issuer_cik":"0001382629","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001382629","owner_cik":"0001382629","owner_name":"Belsky Marc","owner_display_name":"Belsky Marc","owner_url":"/insider/0001382629","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":56.0,"shares_display":"56","price_per_share":5.8,"price_display":"5.80","price_state":"stated","total_value":324.8,"total_display":"324.80","total_whole":"325","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-26","filed_date":"2019-07-26","scope":"insider"},{"id":7871934,"accession":"0001209191-19-043385","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-043385","line_url":"/filing/0001209191-19-043385#line-1","is_derivative":false,"issuer_cik":"0001382629","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001382629","owner_cik":"0001382629","owner_name":"Belsky Marc","owner_display_name":"Belsky Marc","owner_url":"/insider/0001382629","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":444.0,"shares_display":"444","price_per_share":5.654,"price_display":"5.65","price_state":"stated","total_value":2510.376,"total_display":"2,510.38","total_whole":"2,510","shares_owned_after":444.0,"shares_owned_after_display":"444","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-25","filed_date":"2019-07-26","scope":"insider"},{"id":2282129,"accession":"0001209191-16-115785","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-16-115785","line_url":"/filing/0001209191-16-115785","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001382629","owner_name":"Belsky Marc","owner_display_name":"Belsky Marc","owner_url":"/insider/0001382629","role":"Officer (Senior Vice President and CFO)","role_mark":"O","role_mark_label":"Officer (Senior Vice President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34102.0,"shares_display":"34,102","price_per_share":50.00451762359979,"price_display":"50.00","price_state":"stated","total_value":1705254.06,"total_display":"1,705,254.06","total_whole":"1,705,254","shares_owned_after":80927.0,"shares_owned_after_display":"80,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-22","filed_date":"2016-04-26","scope":"insider","n_lines":2},{"id":2178317,"accession":"0001209191-16-113717","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-16-113717","line_url":"/filing/0001209191-16-113717#line-5","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001382629","owner_name":"Belsky Marc","owner_display_name":"Belsky Marc","owner_url":"/insider/0001382629","role":"Officer (Senior Vice President and CFO)","role_mark":"O","role_mark_label":"Officer (Senior Vice President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20814.0,"shares_display":"20,814","price_per_share":45.04,"price_display":"45.04","price_state":"stated","total_value":937462.56,"total_display":"937,462.56","total_whole":"937,463","shares_owned_after":80927.0,"shares_owned_after_display":"80,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-06","filed_date":"2016-04-08","scope":"insider"},{"id":2412741,"accession":"0001209191-16-111280","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-111280","line_url":"/filing/0001209191-16-111280#line-4","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001382629","owner_name":"Belsky Marc","owner_display_name":"Belsky Marc","owner_url":"/insider/0001382629","role":"Officer (Senior Vice President and CFO)","role_mark":"O","role_mark_label":"Officer (Senior Vice President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9052.0,"shares_display":"9,052","price_per_share":40.01,"price_display":"40.01","price_state":"stated","total_value":362170.52,"total_display":"362,170.52","total_whole":"362,171","shares_owned_after":80927.0,"shares_owned_after_display":"80,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-30","filed_date":"2016-03-31","scope":"insider"},{"id":2412733,"accession":"0001209191-16-111280","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-111280","line_url":"/filing/0001209191-16-111280#line-2","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001382629","owner_name":"Belsky Marc","owner_display_name":"Belsky Marc","owner_url":"/insider/0001382629","role":"Officer (Senior Vice President and CFO)","role_mark":"O","role_mark_label":"Officer (Senior Vice President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4824.0,"shares_display":"4,824","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":192960.0,"total_display":"192,960.00","total_whole":"192,960","shares_owned_after":80927.0,"shares_owned_after_display":"80,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-29","filed_date":"2016-03-31","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001645666","name":"Kezar Life Sciences, Inc.","url":"/issuer/0001645666","role":"Officer (CFO)","n_filings":5,"first_seen":"2019-07-26","last_seen":"2020-02-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001175505","name":"FIVE PRIME THERAPEUTICS INC","url":"/issuer/0001175505","role":"Officer (Senior Vice President and CFO)","n_filings":3,"first_seen":"2016-03-31","last_seen":"2016-04-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001382629","retrieved_at":"2026-08-27T15:33:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}